SeekingAlpha · Sep 19, 2026
Harbor SMID Cap Value ETF Q2 2026 Contributors And Detractors
In Q2 2026, the Harbor SMID Cap Value ETF returned 22.76%, outperforming its benchmark, the Russell 2500 Value Index, which returned 18.50%. Read more here.
NASDAQ · CNMD
Healthcare · Medical - Devices
$45.80
Down-$0.37 (-0.80%)
Updated Sep 24, 2026, 2:48 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CNMD closed at $45.80 after 20 trading sessions, down 9.27% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | $45.48 | $46.15 | $44.745 | $45.80 | 491.19K |
| Sep 22, 2026 | $45.37 | $46.545 | $45.22 | $46.17 | 441.78K |
| Sep 21, 2026 | $45.82 | $45.83 | $44.39 | $44.69 | 354.66K |
| Sep 18, 2026 | $45.73 | $46.13 | $45.095 | $45.42 | 780.48K |
| Sep 17, 2026 | $47.31 | $47.31 | $46.07 | $46.13 | 307.1K |
| Sep 16, 2026 | $46.60 | $47.94 | $46.37 | $47.04 | 296.75K |
| Sep 15, 2026 | $46.01 | $47.17 | $45.625 | $46.95 | 458.09K |
| Sep 14, 2026 | $47.32 | $47.32 | $46.17 | $46.38 | 322.59K |
| Sep 11, 2026 | $47.53 | $47.53 | $45.85 | $46.30 | 237.57K |
| Sep 10, 2026 | $46.43 | $47.095 | $45.90 | $46.22 | 240.83K |
| Sep 9, 2026 | $46.61 | $47.20 | $46.08 | $46.93 | 262.29K |
| Sep 8, 2026 | $48.62 | $49.09 | $45.9144 | $46.59 | 331.71K |
| Sep 4, 2026 | $49.09 | $49.515 | $48.61 | $49.32 | 281.28K |
| Sep 3, 2026 | $49.96 | $50.33 | $48.50 | $49.42 | 221.73K |
| Sep 2, 2026 | $49.57 | $50.91 | $49.26 | $49.43 | 299.26K |
| Sep 1, 2026 | $49.79 | $50.13 | $49.00 | $49.12 | 269K |
| Aug 31, 2026 | $49.76 | $50.52 | $49.23 | $49.85 | 288.05K |
| Aug 28, 2026 | $50.20 | $51.12 | $49.87 | $49.98 | 216.41K |
| Aug 27, 2026 | $50.56 | $51.48 | $49.92 | $50.32 | 327.13K |
| Aug 26, 2026 | $50.82 | $51.35 | $49.97 | $50.48 | 188.24K |
The latest Smart Investors Daily articles mentioning CNMD.
CNMD research
Company profile and research snapshot.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 30, 2026 | Piper Sandler | Neutral | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jun 29, 2026 | B of A Securities | Underperform | — |
| May 18, 2026 | B of A Securities | Neutral | — |
No generated briefing is available yet.
SeekingAlpha · Sep 19, 2026
In Q2 2026, the Harbor SMID Cap Value ETF returned 22.76%, outperforming its benchmark, the Russell 2500 Value Index, which returned 18.50%. Read more here.
Yahoo · Sep 18, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Yahoo · Sep 16, 2026
CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.
Yahoo · Sep 3, 2026
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning CNMD.